Clinical Trials
13 trialsNCT07564102 2026-05-15
dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy
Mochida Medical USA, Inc.
Phase 1/2 Not yet recruiting
NCT07590934 2026-05-15
PROSPECTOR
AstraZeneca
Phase 1/2 Not yet recruiting
NCT07570966 2026-05-06
Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Novartis
Phase 1/2 Not yet recruiting
NCT07567521 2026-05-05
A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC
C Ray Therapeutics
Phase 1/2 Not yet recruiting
NCT07567846 2026-05-05
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
Genentech, Inc.
Phase 1/2 Not yet recruiting
NCT07048314 2026-03-19
Stem Cells for Erectile Dysfunction Post RALP
The Methodist Hospital Research Institute
Phase 1/2 Not yet recruiting
NCT07441889 2026-03-02
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
University of Virginia
Phase 1/2 Not yet recruiting
NCT06906471 2026-01-22
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
Antelope Surgical Solutions, Inc
Phase 1/2 Not yet recruiting
NCT07341737 2026-01-15
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
Phase 1/2 Not yet recruiting
NCT06400160 2025-11-25
Clinical Trial of TB511 in Advanced Solid Tumors
Twinpig Biolab, Inc.
Phase 1/2 Not yet recruiting
NCT07104110 2025-08-05
Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT05896371 2025-03-30
PRODIGY-1
CHU de Quebec-Universite Laval
Phase 1/2 Not yet recruiting
NCT06783153 2025-01-20
Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients
Mansoura University
Phase 1/2 Not yet recruiting